Hopefully, this will drive policy changes, lower prices, and expand access, while also marking an important shift: seeing obesity as a disease that deserves proactive, evidence-based treatment. While semaglutide is the most prominent of them all, dulaglutide and liraglutide, as well as the dual GLP-1/GIP agonist GIP plays a similar role to GLP-1 tirzepatide, present in Lillys Mounjaro and Zepbound, also join the list as therapeutic alternatives. Even biosimilars, which are drugs that are highly similar to biologics with regard to their quality, safety, and efficacy, were listed
Will my insurance cover compounded GLP-1 medications
However, retatrutide trial results should not be compared directly with Mounjaro results from separate studies
Now, researchers are asking a bigger question: could these medications also influence breast cancer risk, treatment tolerance, or long-term outcomes
and Huaqing (Xi'an) Natural Ingredients Co.,Ltd lead in regulatory alignment and consistent batch testing
By stimulating insulin secretion, lowering glucagon levels, and slowing down gastric emptying, semaglutide can help reduce hunger and promote a sense of fullness, leading to decreased caloric intake